Second Affiliated Hospital Of Nanchang University

This study tested a combination of two drugs, tislelizumab and anlotinib, in 29 people with advanced pulmonary pleomorphic carcinoma, a rare and aggressive lung cancer. The goal was to see if the combo could shrink tumors or slow the disease. Participants had stage III or IV canc…

This study looked at 698 people with metastatic colorectal cancer to see if chronic inflammation changes how well bevacizumab (a targeted therapy) plus chemotherapy works. Researchers measured inflammation markers in the blood and analyzed immune proteins to find clues about trea…